4basebio PLC (88Q.DE) XETRA
Currency In EUR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 90.64M |
| Enterprise Value | 89.34M |
| P/E Ratio | -4.53 |
| PEG Ratio | 0.33 |
| Price/Sales Ratio | 104.09 |
| Price/Book Ratio | 64.18 |
| Enterprise/Revenue | 115.68 |
| Enterprise/EBITDA | -5.54 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -23.08 |
| Operating Margin | -22.33 |
AD
Management Effectiveness
| Return On Assets | -0.66 |
| Return On Equity | -3.17 |
Income Statement
| Revenue | 1.69M |
| Revenue/Share | 0.05 |
| Gross Profit | 548,348 |
| EBITDA | -15.59M |
| Net Income | -16.92M |
| Diluted EPS | -1.09 |
Balance Sheet
| Total Cash | 13.97M |
| Total Cash/Share | 0.9 |
| Total Debt | 22.98M |
| Total Debt/Equity | 18.18 |
| Current Ratio | 5.98 |
| Book Value Per Share | 0.08 |
Price History
| 52-Week Change | -26.11 |
| 52-Week High | 9.15 |
| 52-Week Low | 4.64 |
| Moving Average 50 Days | 5.95 |
| Moving Average 200 Days | 5.95 |
Statistics
| Average Volume | 152 |
| Shares Outstanding | 15.48M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
